Arkolith/Insider Trading/TLSI/Form 4

Wahlstrom Mats

Director, 10% OwnerTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed Feb 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 10, 2025Other(J)45K—$095K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-003621) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML